TY - JOUR T1 - Spread of COVID-19 in India: A Simple Algebraic Study JF - medRxiv DO - 10.1101/2020.05.10.20097691 SP - 2020.05.10.20097691 AU - Sudipto Roy Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/05/14/2020.05.10.20097691.abstract N2 - The number of patients, infected with COVID-19, began to increase very rapidly in India from March 2020. The country was put under lockdown from 25 March 2020. The present study is aimed at providing a simple algebraic analysis of the trend that is evident in the spread of the disease in this part of the world. The purpose of this algebraic approach is to simplify the calculation sufficiently by deviating from the standard techniques that are conventionally used to construct mathematical models of epidemics. The predictions, obtained from this algebraic study, are found to be in reasonable agreement with the recorded data. Using this mathematical formulation we have determined the time variation of the number of asymptomatic patients, who are believed to play a major role in spreading the disease. We have discussed the effect of lockdown in reducing the rate of transmission of the disease. On the basis of the proposed models, predictions have been made regarding the possible trend of the rise in the number of cases beyond the withdrawal of lockdown. All these things have been calculated by using very simple mathematical expressions which can be easily understood and used by those who have a rudimentary knowledge of algebra.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding has been received for the present research.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesFor the present study we have used the data regarding the number of confirmed COVID-19 cases in India during the period from 01 March 2020 to 03 May 2020. These data have been obtained from the website of the Ministry of Health and Family Welfare, Government of India. Apart from this, we have used the website of the World Health Organization (WHO) to obtain the present number of COVID-19 infections in the world. These sources of data have been mentioned in the article and we have provided their web-links in the 3rd and 14th entries of the section of 'References' at the end of the paper. ER -